Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


Recent & Breaking News (TSX:EDT)

Spectral Medical's Dialco Medical Announces 20 Year Exclusive License Agreement for DIMI Hemodialysis System in the United States and Canada

GlobeNewswire April 8, 2021

Spectral Medical (TSX:EDT) subsidiary Dialco Medical announces receipt of Health Canada license for DIMI

Julia Kennedy  March 31, 2021

Spectral Medical's Wholly-Owned Subsidiary Dialco Medical Announces Receipt of Health Canada License for DIMI

GlobeNewswire March 31, 2021

Spectral Medical (TSX:EDT) releases financial results and shares positive results from the Tigris program

Julia Kennedy  March 26, 2021

Spectral Announces Fourth Quarter and Fiscal 2020 Results and Corporate Update

GlobeNewswire March 26, 2021

Spectral Medical (TSX:EDT) appoints Chris Seto as CEO

John Ballem  March 8, 2021

Spectral Medical Announces the Appointment of Chris Seto to CEO

GlobeNewswire March 8, 2021

Spectral Medical (TSX:EDT) engages Crescendo Communications to provide Investor Relations Services

John Ballem  March 4, 2021

Spectral Medical Engages Crescendo Communications to Provide Investor Relations Services in the United States

GlobeNewswire March 4, 2021

Spectral Medical to participate at the upcoming H.C. Wainwright Global Life Sciences Conference

GlobeNewswire March 2, 2021

Spectral Medical (TSX:EDT) subsidiary Dialco Medical granted FDA IDE authorization for a DIMI trial for home Hemodialysis use

John Ballem  February 23, 2021

Spectral Medical Announces that its Wholly-Owned Subsidiary Dialco Medical has been Granted FDA IDE Authorization to Conduct a Trial of DIMI for Home Hemodialysis Use

GlobeNewswire February 23, 2021

Spectral Medical (TSX:EDT) appoints Dr. John Kellum as Chief Medical Officer

Isabella Zavarise February 1, 2021

Spectral Medical Appoints Dr. John Kellum as Chief Medical Officer

GlobeNewswire February 1, 2021

Spectral Medical to Present at the H.C. Wainwright Virtual BioConnect Conference

GlobeNewswire January 11, 2021

Spectral Medical to Present at the SNN Network Canada Virtual Event on January 7, 2021

GlobeNewswire January 6, 2021

Keynotes, Educational Panels and 42 Canadian-Listed Public Companies to Present at the SNN Network Canada Virtual Event on January 6-7, 2021

Accesswire January 5, 2021

Spectral Medical to Host Virtual Investor Day on December 4, 2020

GlobeNewswire November 27, 2020

Spectral Medical Announces that its wholly owned subsidiary Dialco Medical has received MDSAP certification

GlobeNewswire November 24, 2020

Spectral Announces Third Quarter Results

GlobeNewswire November 11, 2020